AcelRx Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
/PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of...
Source: prnewswire.com